Summary:
RSV Vaccine Study – Now Enrolling Adults 60+
Qualified Participants Must:
• Are you 60 or older? You may qualify for a clinical research study evaluating an FDA-approved RSV vaccine (Abryvso).
Qualified Participants May Receive:
Qualified participants will receive:
✔ Study-related care at no cost
✔ Up to $$ compensation
✔ Travel reimbursement
✔ No insurance or copays required
Spots are limited — contact us today to see if you’re eligible!